Open AccessFEATURES OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH FUNCTIONAL INTESTINAL DISORDERS
Author(s) -
І. G. Kryvoruchko,
І. М. Skrypnyk,
N. P. Prykhodko,
О.В. Scherbak,
L.I. Yakimishina
Publication year - 2021
Publication title -
aktualʹnì problemi sučasnoï medicini: vìsnik ukraïnsʹkoï medičnoï stomatologìčnoï akademì
Language(s) - English
Resource type - Journals
eISSN - 2077-1126
pISSN - 2077-1096
DOI - 10.31718/2077-1096.21.4.43
Subject(s) - irritable bowel syndrome , bloating , anxiety , medicine , constipation , gastroenterology , depression (economics) , functional constipation , subclinical infection , diarrhea , psychiatry , economics , macroeconomics
Functional intestinal diseases are often accompanied by the development of anxiety and depressive disorders, which are an important medical and social issue. The aim of this study is to investigate the prevalence and severity of anxiety and depressive disorders in patients with functional intestinal disorders depending on gender. Materials and methods. The study included 165 patients divided into 6 groups depending on the phenotype of functional bowel disorder: group I (n = 27) involved patients with functional constipation; group II (n = 28) included patients with functional bloating; group III (n = 27) comprised patients with functional diarrhoea; group IV (n = 27) included patients with irritable bowel syndrome and constipation; group V (n = 27) involved patients with irritable bowel syndrome of mixed type; and group VI (n = 29) included patients with irritable bowel syndrome and diarrhoea. The presence of anxiety and depression was assessed using the Hospital Anxiety and Depression Scale. Results and discussion. The highest frequency and severity of anxiety disorder was registered in the group of patients with irritable bowel syndrome and diarrhoea, and the lowest level was found in patients with functional constipation, bloating and diarrhoea. Subclinical and clinical manifestations of depression were the most often observed in patients with different phenotypes of irritable bowel syndrome: in 13 (48.2%) patients with constipation, in 10 (37%) with mixed syndrome and in 8 (27.6%) with diarrhoea. The incidence of anxiety and depressive disorders was higher in women with irritable bowel syndrome. Our results confirm the importance of pain in the formation of anxiety and depressive disorders in IBS patients. Conclusion. Female patients with irritable bowel syndrome demonstrate the higher risk of anxiety and depressive disorders.